American journal of health-system pharmacy : AJHP

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists[Journal]: Latest results from PubMed
  1. CONCLUSION: This novel approach is applicable to systematic reviews and ongoing review series, including those for the MUP and ACMUP. Pharmacists have a duty to review and incorporate best practices into their organizations to improve the efficiency and cost of care, optimally utilize technology, and reduce the potential for medication errors. This methodology will allow evidence syntheses for the MUP and other disciplines in pharmacy practice to be published more expeditiously by saving...
  2. CONCLUSION: This study demonstrated the important role of clinical pharmacy services in controlling CINV and enhancing the overall treatment experience for patients with cancer. Further studies with standardized pharmacists' services and outcome measures are needed to validate our findings.
  3. CONCLUSION: Whilst there is some evidence of positive impacts of pharmacist intervention on clinical outcomes and optimizing drug therapy, this evidence is generally of low quality and insufficient volume. While this review suggests that pharmacists have essential roles in improving the care of patients undergoing surgery, more research with rigorous designs is required.
  4. CONCLUSION: Data from 12 publications and across 36 patients suggests that the use of DOACs in the acute phase of HIT may be a safe and efficacious treatment option with favorable ease of monitoring and management.
  5. CONCLUSION: Pharmacy resident research project publication rates are low at 13%. Furthermore, studies reporting project publication rates over time suggest a neutral or negative trend in publication rates despite an exponential increase in the number of pharmacy residents.
  6. CONCLUSION: Communication barriers exist. Qualified sign language interpreters and assistive technology should be used to improve communication.
  7. CONCLUSION: These results suggest low- and high-dose 4F-PCC may confer similar clinical effectiveness and safety; however, these findings should be evaluated and confirmed with future prospective studies.
  8. CONCLUSION: The risk of any type of bleeding was significantly increased among patients taking aspirin plus OAC compared to those taking OAC alone in both RCTs and observational studies. Evaluation of RCTs comparing OAC plus aspirin to aspirin alone suggests increased bleeding risk as well.